Trials / Enrolling By Invitation
Enrolling By InvitationNCT07334353
Consensus Guidelines for Pre- and Post-Procedure Skincare in Aesthetic Treatments
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (estimated)
- Sponsor
- Venus Research Center · Academic / Other
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
This consensus protocol outlines standardized pre- and post-procedure skincare practices designed to optimize treatment outcomes, enhance skin recovery, and minimize complications following aesthetic procedures. It provides evidence-based guidance for skin preparation before treatment and structured aftercare to support healing, reduce inflammation, prevent infection, and maintain long-term results.
Detailed description
This protocol presents a Delphi-based expert consensus on standardized pre- and post-procedure skincare for aesthetic treatments, developed to optimize clinical outcomes, enhance patient safety, and minimize procedure-related complications. The recommendations apply to a broad spectrum of aesthetic interventions, including injectables, laser and energy-based devices, chemical peels, microneedling, and combination therapies. Consensus Development Methodology (Delphi Method) This protocol is developed using the Delphi method, a structured, iterative process designed to achieve expert agreement through multiple rounds of anonymous feedback. A multidisciplinary panel of experienced aesthetic physicians, dermatologists, and skincare experts participates in sequential survey rounds. Each round refines key recommendations based on: * Aggregated expert responses * Controlled feedback * Statistical agreement thresholds This approach ensures that the final protocol reflects high-level expert agreement, minimizes bias, and supports evidence-informed clinical decision-making.
Conditions
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2026-12-01
- Completion
- 2027-02-01
- First posted
- 2026-01-12
- Last updated
- 2026-01-12
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07334353. Inclusion in this directory is not an endorsement.